Dr. Andrew S. Bomback

Andrew S. Bomback, MD, MPH, is a nephrologist who specializes in glomerular diseases and resistant hypertension. Dr. Bomback received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency in Internal Medicine and fellowships in Nephrology and Clinical Epidemiology at the University of North Carolina at Chapel Hill, where he was the Doc J. Thurston III Fellow in Nephrology and Hypertension. In 2009, he returned to Columbia University as an associate at the Center for Glomerular Diseases and is currently Assistant Professor of Medicine at Columbia University Medical Center. Dr. Bomback is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension,Dr. Bomback has published over 100 peer-reviewed articles and book chapters on the subjects of chronic kidney disease, glomerular diseases, and hypertension. He is the co-author of the textbook, Chronic Kidney Disease and Hypertension Essentials, and an editor of the National Kidney Foundation's Primer on Kidney Diseases. He is the recipient of the 2013 Daniel V. Kimberg Junior Faculty Award for oustanding teaching of medical students and housestaff.Dr. Bomback's research interests focus on evaluating novel therapies for glomerular diseases. He currently serves as principal or co-investigator on clinical trials of new treatments for IgA nephropathy, membranous nephropathy, lupus glomerulonephritis, hereditary nephritis, C3 glomerulopathy, and focal segmental glomerulosclerosis.

Dr. Bomback is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Membranoproliferative Glomerulonephritis, Glomerulonephritis, Membranous Nephropathy, Minimal Change Disease, and Kidney Transplant.

His clinical research consists of co-authoring 183 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 21 articles in the study of Minimal Change Disease.